Register Login

KYMERA THERAPEUTICS, INC. (KYMR)

Chadwick Jeremy G 🟡 adjusted position in 22.2K shares (2 derivative) of Kymera Therapeutics, Inc. (KYMR) at $86.05 ($3.2M) Transaction Date: Mar 31, 2026 | Filing ID: 138371

Full text
Register to leave comments
  • News bot April 1, 2026, 11 p.m.

    🔍 Chadwick Jeremy G (Executive)

    Company: Kymera Therapeutics, Inc. (KYMR)

    Report Date: 2026-03-31

    Transaction Summary:

    • Total transactions: 7
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 22,240
    • Total shares sold: 44,480

    Detailed Transactions and Holdings:

    • Acquired 7,600 shares of Common Stock at $29.64 per share (Direct)
      Date: 2026-03-31 | Code: M | equity_swap_involved: false | shares_owned_after: 68,802.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 7,600 shares of Common Stock at $85.3792 per share (Direct)
      Date: 2026-03-31 | Code: S | equity_swap_involved: false | shares_owned_after: 61,202.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 14,640 shares of Common Stock at $29.64 per share (Direct)
      Date: 2026-04-01 | Code: M | equity_swap_involved: false | shares_owned_after: 75,842.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 13,540 shares of Common Stock at $85.4144 per share (Direct)
      Date: 2026-04-01 | Code: S | equity_swap_involved: false | shares_owned_after: 62,302.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 1,100 shares of Common Stock at $86.05 per share (Direct)
      Date: 2026-04-01 | Code: S | equity_swap_involved: false | shares_owned_after: 61,202.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 7,600 shares of Stock Option (Right to Buy) at $29.64 per share (Derivative)
      Date: 2026-03-31 | Code: M | Expires: 2033-05-22 | equity_swap_involved: false | shares_owned_after: 83,273.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 14,640 shares of Stock Option (Right to Buy) at $29.64 per share (Derivative)
      Date: 2026-04-01 | Code: M | Expires: 2033-05-22 | equity_swap_involved: false | shares_owned_after: 68,633.00 | transaction_form_type: 4 | Footnotes: F1, F4

    Footnotes:

    • F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person.
    • F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.02 to $85.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F4: Twenty-five percent (25%) of the shares underlying this stock option vested on May 22, 2024 and the remaining shares shall vest in equal monthly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.

Search

News categories